Northwest Bioth Cmn (NWBO)

$0.26 +0.00 (1.65%)
Market Cap 405.51M
Revenue (ttm) 1.38M
Net Income (ttm) -83.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,071.01%
Debt to Equity Ratio 0.00
Volume 1,867,600
Avg Vol 3,407,590
Day's Range N/A - N/A
Shares Out 1.59B
Stochastic %K 28%
Beta -0.86
Analysts Strong Buy
Price Target $2.00

Company Profile

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inop...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 497 9024
Address:
4800 Montgomery Lane, Suite 800, Bethesda, United States
Driley910
Driley910 Apr. 5 at 4:16 PM
$NWBO
0 · Reply
Vshndyp
Vshndyp Apr. 5 at 3:41 PM
$NWBO … MHRA … what are you waiting for … WHAT !!?? https://youtu.be/Yg3zULcIYSY
1 · Reply
plotdog
plotdog Apr. 5 at 3:05 PM
$NWBO Happy Easter, He has Risen
2 · Reply
wjmax
wjmax Apr. 5 at 3:03 PM
$NWBO $VCNX Amazing results can be seen in animal model about the combination of DC vaccine with SEMA4D blockade. A human trial is undergoing which has primary completion time set for April. What would happen when the trial results are out?! Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /​Trastuzumab in Patients w/​ Metastatic HER2+ Breast Cancer https://clinicaltrials.gov/study/NCT05378464
1 · Reply
wjmax
wjmax Apr. 5 at 2:56 PM
$NWBO $VCNX It seems like Merck has been testing the combination of its keytruda with various treatments either complementary to or synergistic with DCVax! $VCNX, an OTC company, is the only one that has SEMA4D blockade. https://clinicaltrials.gov/study/NCT04815720
0 · Reply
wjmax
wjmax Apr. 5 at 2:09 PM
$NWBO $VCNX Absolutely amazing results! https://www.cell.com/cell-reports/fulltext/S2211-1247(26)00128-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124726001282%3Fshowall%3Dtrue
0 · Reply
DeepThought
DeepThought Apr. 5 at 1:41 PM
$NWBO Some trees spend years building roots no one sees. The Pandanus tectorius is one of them — it grows slowly, quietly, and without applause, investing its energy into foundations that look like delay to the untrained eye. But once it is ready, it produces a fruit unlike anything around it, something that could not have existed without that long, invisible preparation. It’s a reminder that certain living systems — and certain companies — follow timelines that outsiders often misunderstand, because their value emerges only after the groundwork is complete!
0 · Reply
pepinjax
pepinjax Apr. 5 at 1:38 PM
$NWBO Happy & Blessed Easter!
2 · Reply
ICEMAN805
ICEMAN805 Apr. 5 at 1:33 PM
$NWBO Happy Easter!
1 · Reply
BradBreath
BradBreath Apr. 5 at 12:33 PM
$NWBO month # 4 Nothing , soon , this month , next meeting , inevitable, block buster, well maybe block busted🤷🏻‍♂️, Hmm what else have herd , M& A ,, MHRA under review ,,, no hope in dope , or nwbo and cvm 😟 just been hearing all this for last 12 months + Just saying 🤷‍♂️
0 · Reply
Latest News on NWBO
No data available.
Driley910
Driley910 Apr. 5 at 4:16 PM
$NWBO
0 · Reply
Vshndyp
Vshndyp Apr. 5 at 3:41 PM
$NWBO … MHRA … what are you waiting for … WHAT !!?? https://youtu.be/Yg3zULcIYSY
1 · Reply
plotdog
plotdog Apr. 5 at 3:05 PM
$NWBO Happy Easter, He has Risen
2 · Reply
wjmax
wjmax Apr. 5 at 3:03 PM
$NWBO $VCNX Amazing results can be seen in animal model about the combination of DC vaccine with SEMA4D blockade. A human trial is undergoing which has primary completion time set for April. What would happen when the trial results are out?! Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /​Trastuzumab in Patients w/​ Metastatic HER2+ Breast Cancer https://clinicaltrials.gov/study/NCT05378464
1 · Reply
wjmax
wjmax Apr. 5 at 2:56 PM
$NWBO $VCNX It seems like Merck has been testing the combination of its keytruda with various treatments either complementary to or synergistic with DCVax! $VCNX, an OTC company, is the only one that has SEMA4D blockade. https://clinicaltrials.gov/study/NCT04815720
0 · Reply
wjmax
wjmax Apr. 5 at 2:09 PM
$NWBO $VCNX Absolutely amazing results! https://www.cell.com/cell-reports/fulltext/S2211-1247(26)00128-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124726001282%3Fshowall%3Dtrue
0 · Reply
DeepThought
DeepThought Apr. 5 at 1:41 PM
$NWBO Some trees spend years building roots no one sees. The Pandanus tectorius is one of them — it grows slowly, quietly, and without applause, investing its energy into foundations that look like delay to the untrained eye. But once it is ready, it produces a fruit unlike anything around it, something that could not have existed without that long, invisible preparation. It’s a reminder that certain living systems — and certain companies — follow timelines that outsiders often misunderstand, because their value emerges only after the groundwork is complete!
0 · Reply
pepinjax
pepinjax Apr. 5 at 1:38 PM
$NWBO Happy & Blessed Easter!
2 · Reply
ICEMAN805
ICEMAN805 Apr. 5 at 1:33 PM
$NWBO Happy Easter!
1 · Reply
BradBreath
BradBreath Apr. 5 at 12:33 PM
$NWBO month # 4 Nothing , soon , this month , next meeting , inevitable, block buster, well maybe block busted🤷🏻‍♂️, Hmm what else have herd , M& A ,, MHRA under review ,,, no hope in dope , or nwbo and cvm 😟 just been hearing all this for last 12 months + Just saying 🤷‍♂️
0 · Reply
DeepThought
DeepThought Apr. 5 at 12:24 PM
$NWBO A little epic for this post from my Easter vacation!
0 · Reply
bigbigwin
bigbigwin Apr. 5 at 9:42 AM
$NWBO P.2 After updated LICENSED of HTA
0 · Reply
bigbigwin
bigbigwin Apr. 5 at 9:41 AM
$NWBO P.1
0 · Reply
bernardkeogh
bernardkeogh Apr. 5 at 8:40 AM
$NWBO
0 · Reply
Surforever
Surforever Apr. 5 at 7:18 AM
$NWBO @NeverUpOnlyDown Wow. Nice find! Nailed it. The inspection report dated 10/9/25 says: Report sent to DI for factual accuracy: 5 January 2026 Report returned from DI: 6 January 2026 Final report issued: 10 February 2026 And if you read the Appendixes, I believe the HTA had it's hands full inspecting Advent. "Appendix 3: HTA standards - The HTA standards applicable to this establishment are shown below; those not assessed during the inspection are shown in grey text." The list is really incredible. It would make complete sense we're in the final stages now and days/weeks away - not months. And there's also a good little nugget in there as well on pg 14: "n) The establishment ensures imports from third countries meet the standards of quality and safety set out in Directions 001/2021."
0 · Reply
Driley910
Driley910 Apr. 4 at 10:34 PM
$NWBO
0 · Reply
marzansmith
marzansmith Apr. 4 at 8:22 PM
$NWBO Quantum won $700M spoofing lawsuit https://x.com/zsaeed/status/2039531152839528885?s=20
4 · Reply
NeverUpOnlyDown
NeverUpOnlyDown Apr. 4 at 6:40 PM
$NWBO Interesting theory about the HTA license and how it could relate to the MAA approval. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177468144
2 · Reply
Ablidy
Ablidy Apr. 4 at 3:50 PM
$NWBO
0 · Reply
Makeitcometrue
Makeitcometrue Apr. 4 at 2:38 PM
$NWBO Hey, to all of the crybabies that block me, do you block the company’s data or market charts since they say the exact same thing that I do????? I mean that is where I get my info and talking points!! Morons😂😂😂😂😂
1 · Reply
Makeitcometrue
Makeitcometrue Apr. 4 at 2:34 PM
$NWBO Why discuss other stocks on this board???? This is the NWBO thread so I post irrefutable facts about this stock. My thoughts about other stocks are irrelevant on this thread! The serious problem, actually telling problem, is how you try to deflect from the obvious fallings of this stock to irrelevant bs. Pathetic, Bum!😂😂😂🤣🤣🤣🤣🤣🤣 5/10/22 OTC $0.20’s and no whales touching this! 😂😂😂😂🤣🤣🤣🤣
1 · Reply
mymadeupname
mymadeupname Apr. 4 at 2:32 PM
$NWBO
0 · Reply